Clofezone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H20N2O2.C14H21ClN2O2.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TPT3MH65LD, chemically known as 2-(4-chlorophenoxy)-n-(2-(diethylamino)ethyl)acetamide, compound with 4-butyl-1,2-diphenyltetrahydropyrazol-3,5-dione (1:1) but generally known as clofezone, which bears US NIH Compound Identifier 6433695. European Medicines Agency schedules Clofezone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06705MIG. World Health Organization schedules clofezone in its Anatomical Therapeutic Chemical (ATC) Classification. CLOFEZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clofezone under HS 29331990 and SITC 51571. As of Q4 2014, CLOFEZONE remains the US FDA Preferred Term for this commodity. Clofezone bears US NLM identifiers UMLS ID C0650237 and NCI Concept Code C77346. SMILES: CLC1CCC(OCC(=O)NCCN(CC)CC)CC1.O=C1N(N(C(=O)C1CCCC)C1CCCCC1)C1CCCCC1.